Gilles Montalescot
www.action-coeur.org
0000-0003-0824-6809
9 papers found
Refreshing results…
Impact of Center Volume on Outcomes in Myocardial Infarction Complicated by Cardiogenic Shock: A CULPRIT‐SHOCK Substudy
Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data
COVID‐19 Associated Thrombosis and Coagulopathy: Review of the Pathophysiology and Implications for Antithrombotic Management
Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial
Effects of ON-Hours Versus OFF-Hours Admission on Outcome in Patients With Myocardial Infarction and Cardiogenic Shock
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis
Do we need a new P2Y12 receptor antagonist?
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
Missing publications? Search for publications with a matching author name.